{"format":1,"id":"118-hr-1076","congress":118,"number":"H.R. 1076","kind":"bill","group":"bills","title":"Preventing the Financing of Illegal Synthetic Drugs Act","title_source":"Short Title(s) as Passed House","official_title":"To require the Comptroller General of the United States to carry out a study on the trafficking into the United States of synthetic drugs, and related illicit finance, and for other purposes.","titles":[{"type":"Official Title as Introduced","title":"To require the Comptroller General of the United States to carry out a study on the trafficking into the United States of synthetic drugs, and related illicit finance, and for other purposes."},{"type":"Short Titles from ENR (Enrolled) bill text","title":"Preventing the Financing of Illegal Synthetic Drugs Act"},{"type":"Display Title","title":"Preventing the Financing of Illegal Synthetic Drugs Act"},{"type":"Short Titles from RFS (Referred to Senate) bill text","title":"Preventing the Financing of Illegal Synthetic Drugs Act"},{"type":"Short Title(s) as Introduced","title":"Preventing the Financing of Illegal Synthetic Drugs Act"},{"type":"Short Title(s) as Reported to House","title":"Preventing the Financing of Illegal Synthetic Drugs Act"},{"type":"Short Title(s) as Passed House","title":"Preventing the Financing of Illegal Synthetic Drugs Act"}],"outcome":"became_law","law_number":"Public Law 118-79","introduced":"2023-02-17","chambers":{"house":{"status":"roll_call","date":"2023-05-22","vote":{"id":"118-2023-h228","question":"On Motion to Suspend the Rules and Pass, as Amended","title":"Preventing the Financing of Illegal Synthetic Drugs Act","result":"Passed","yea":402,"nay":2,"present":0,"not_voting":30,"source":"https://clerk.house.gov/evs/2023/roll228.xml"}},"senate":{"status":"voice","date":"2024-07-23","vote":null,"how":"unanimous_consent","words":"Passed/agreed to in Senate: Passed Senate without amendment by Unanimous Consent."}},"president":{"status":"signed","date":"2024-09-13"},"vice_president_tie_breaker":null,"latest_action":{"text":"Became Public Law No: 118-79.","date":"2024-09-13"},"nominees":null,"amendments":[],"other_votes":[],"crs_summary":{"date":"2024-09-13","stage":"Public Law","blocks":[{"k":"h","t":"Preventing the Financing of Illegal Synthetic Drugs Act"},{"k":"p","t":"This bill requires the Government Accountability Office to carry out a study on illicit financing in connection with the trafficking of synthetic drugs, including fentanyl and methamphetamine, fentanyl- and methamphetamine-related substances, Captagon, and fentanyl and methamphetamine precursors, and to report to Congress."}],"words":50},"summary":{"main_subject":{"text":"Requires the Comptroller General of the United States to carry out a study on illicit financing connected to the trafficking of synthetic drugs and to report the findings to Congress.","cites":[{"label":"Sec. 3","href":"https://www.congress.gov/bill/118th-congress/house-bill/1076/text/enr#H56431F345FE34CC9B43EB1302A7E4CB3:~:text=3.%20GAO%20study%20on%20synthetic%20drugs%20trafficking"}]},"core_areas":["GAO study of illicit finance in synthetic drug trafficking","Report to Congress on study findings"],"what_it_does":[{"text":"Requires the Comptroller General of the United States to carry out a study on illicit financing in connection with the trafficking of synthetic drugs, including fentanyl and methamphetamine, Captagon, related substances, and precursors.","cite":{"label":"Sec. 3","href":"https://www.congress.gov/bill/118th-congress/house-bill/1076/text/enr#H56431F345FE34CC9B43EB1302A7E4CB3:~:text=3.%20GAO%20study%20on%20synthetic%20drugs%20trafficking"}},{"text":"Directs the study to cover the business of synthetic drug trafficking and related illicit finance, including transnational criminal organizations, terror syndicates, and trafficking corridors through source and transit countries.","cite":{"label":"Sec. 3","href":"https://www.congress.gov/bill/118th-congress/house-bill/1076/text/enr#H56431F345FE34CC9B43EB1302A7E4CB3:~:text=3.%20GAO%20study%20on%20synthetic%20drugs%20trafficking"}},{"text":"Directs the study to cover the business models of these organizations, from precursor purchase or production through manufacture, marketing, distribution, sales, and return of proceeds.","cite":{"label":"Sec. 3","href":"https://www.congress.gov/bill/118th-congress/house-bill/1076/text/enr#H56431F345FE34CC9B43EB1302A7E4CB3:~:text=3.%20GAO%20study%20on%20synthetic%20drugs%20trafficking"}},{"text":"Directs the study to cover the use of online illicit drug markets, social media applications, and payment applications for marketing, sale, and payment for synthetic drugs.","cite":{"label":"Sec. 3","href":"https://www.congress.gov/bill/118th-congress/house-bill/1076/text/enr#H56431F345FE34CC9B43EB1302A7E4CB3:~:text=3.%20GAO%20study%20on%20synthetic%20drugs%20trafficking"}},{"text":"Directs the study to cover financial methods used by these organizations, including payment, money laundering, and repatriation of proceeds.","cite":{"label":"Sec. 3","href":"https://www.congress.gov/bill/118th-congress/house-bill/1076/text/enr#H56431F345FE34CC9B43EB1302A7E4CB3:~:text=3.%20GAO%20study%20on%20synthetic%20drugs%20trafficking"}},{"text":"Requires the Comptroller General to issue a report to Congress with all findings and determinations from the study within 1 year after the date of enactment.","cite":{"label":"Sec. 3","href":"https://www.congress.gov/bill/118th-congress/house-bill/1076/text/enr#H56431F345FE34CC9B43EB1302A7E4CB3:~:text=3.%20GAO%20study%20on%20synthetic%20drugs%20trafficking"}}],"unexpected":[],"version":{"type":"Enrolled Bill","date":null,"rule":"enrolled","href":"https://www.congress.gov/bill/118th-congress/house-bill/1076/text/enr"},"current":true,"model":"claude-sonnet-5-5","approved":"2026-09-30","approved_by":"checks"},"sources":{"congress_gov":"https://www.congress.gov/bill/118th-congress/house-bill/1076","text":"https://www.congress.gov/bill/118th-congress/house-bill/1076/text"},"card":{"image":"card/item/118-hr-1076.png","v":"78fb89e60b1e","alt":"Votes on Record. H.R. 1076, 118th Congress: Preventing the Financing of Illegal Synthetic Drugs Act. House: 402 Yea, 2 Nay. Senate: unanimous consent. Outcome: Became law, 13 Sep 2024."}}